Skip to content

Comparison of Surgical Pleth Index with Nocieption index Monitoring on Application of remifentanil and Postoperative-related complications During Propofol–Remifentanil Anesthesia

Comparison of Surgical Pleth Index with Nocieption index Monitoring on Application of remifentanil and Postoperative-related complications During Propofol–Remifentanil Anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062346
Enrollment
Unknown
Registered
2022-08-02
Start date
2022-08-05
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The use of opioids under Anesthesia and Analgesia Monitoring

Interventions

SPI group, NOX group and routine medication group:Using two different monitoring methods for analgesia

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.ASA grade between 18 and 65 years old: 2.Patients with ASA grade I or II were selected, NYHA grade I or II, BMI 18-30kg/m^2; 3.Type of operation: elective non-brain surgery under general anesthesia; 4.The duration of the operation is expected to be at least 1 hour.

Exclusion criteria

Exclusion criteria: 1. Suffer from mental, nervous system, suspected dementia or memory impairment; 2. Patients with a clear history of central nervous system disease, mental illness and epilepsy; 3. Patients with impaired language communication, hearing and vision, unable to complete the evaluation of autonomic nervous function; 4.Critical condition (ASAIV grade or above), severe liver and kidney disease; 5.Take drugs that affect the autonomic nervous system (including ß-blockers, cardiotonic glycosides); 6. History of allergy to general and local anesthetics, drug and alcohol abuse; 7. Refusing to be included in clinical observation.

Design outcomes

Primary

MeasureTime frame
Remifentanil Consumption;

Countries

China

Contacts

Public ContactShiyuan Xu

Zhujiang Hospital of Southern Medical University

Xsy998@smu.edu.cn+86 13409727860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026